Obestatin (human) ELISA kit

PRODUCT EXPLANATION: ACETYLCHOLINESTERASE MARKER IN ENZYME-IMMUNOASSAYS|Grassi J., Pradelles P. Compounds labelled by the acetylcholinesterase of Electrophorus Electricus. Its preparation process and its use as a tracer or marquer in enzymo-immunological determinations. United States patent, N° 1,047,330. September 10, 1991|Grassi J., Pradelles P. The use of Acetylcholinesterase as a Universal marker in Enzyme-Immunoassays. Proceedings of the Third International Meeting on Cholinesterases, American Chemical Society (1991)|Pradelles P., Grassi J., Maclouf J. Enzyme Immunoassays of Eicosanoids Using Acetylcholinesterase. Methods in Enzymology (1990), vol. 187, 24-34|PRODUCT EXPLANATION: OBESTATIN|Alen B, Nieto L, Gurriaran-Rodriguez U et al. The NMR Structure of Human Obestatin in Membrane-Like Environments: Insights into the Structure-Bioactivity Relationship of Obestatin. PLOS ONE | www.plosone.org, vol. 7, Issue 10, e45434 2012|Zhang J.V, Ren P.G, Avsian-Kretchmer O et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin’s effects on food intake. Science 310 996-999, 2005|Gronberg M, Tsolakis AV, Magnusson L et al. Distribution of obestatin and ghrelin in human tissues: immunoreactive cells in the gastrointestinal tract, pancreas, and mammary glands. J Histochem Cytochem ;56 :793-801, 2008|Granata R, Baragli A, Settanni F et al. Unraveling the role of the ghrelin gene peptides in the endocrine pancreas. J Mol Endocrinol ;45 :107-118, 2010|Ren AJ, He Q, SHI JS et al. Association of obestatin with blood pressure in the third trimesters of pregnancy. Peptides ;30 :1742-1745 ;2009|Li ZF, Guo ZF, Cao J et al. Plasma ghrelin and obestatin levels are increased in spontaneously hypertensive rats. Peptides ;31 :297-300 ;2010|Carlini VP, Schioth HB and Debarioglio SR. Obestatin improves memory performance and causes anxiolytic effects in rats. Biochem Biophys Res Commun ;352 :907-12, 2007|PRODUCT EXPLANATION: KIT DEVELOPMENT|Valentin MA, Ma S, Zhao A et al. Validation of immunoassay for protein biomarkers: Bioanalytical study plan implementation to support pre-clinical and clinical studies. J Pharm Biomed Anal. (2011) 55(5): 869-877|European Medicines Agency. Guideline on bioanalytical method validation, 21 July 2011